Products found to contain undeclared medicines
|
| |
| The United States: Public Notification: Baschi Quick Slimming Capsule contains hidden drug ingredients sibutramine and N-desmethylsibutramine |
| |
The US Food and Drug Administration (FDA) is advising consumers not to purchase or use Baschi Quick Slimming Capsule, a product promoted for weight loss. This product was identified during an examination of international mail shipments. FDA laboratory analysis confirmed that Baschi Quick Slimming Capsule contains sibutramine and N-desmethylsibutramine. Sibutramine is a controlled substance that was removed from the market in October 2010 for safety reasons. N-desmethylsibutramine is a substance structurally similar to sibutramine. The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or heart rate in some people and may present a significant risk for people with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This product may also interact, in life-threatening ways, with other medications a consumer may be taking.
Please refer to the following website in FDA for details:
http://www.fda.gov/Drugs/ResourcesForYou/../ucm622104.htm
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Tuesday, Oct 2, 2018
Issued at HKT 17:30
|
| |
